Pharma Bio Serv Inc (PBSV) Analysts See $-0.01 EPS

August 11, 2017 - By Peter Erickson

 Pharma Bio Serv Inc (PBSV) Analysts See $ 0.01 EPS

Investors wait Pharma Bio Serv Inc (OTCMKTS:PBSV) to report on September, 13. its quarterly earnings Wall Street analysts expect $-0.01 earnings per share, $0.00 or 0.00 % from last year’s $-0.01 same quarter earnings. Pharma Bio Serv Inc’s Wall Street analysts see 0.00 % EPS growth, taking into account the $-0.01 EPS reproted in the previous quarter, It is down 0.00% since August 11, 2016 and is . It has underperformed by 16.70% the S&P500.

Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The company has market cap of $15.59 million. The Firm operates through four divisions: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division . It currently has negative earnings. The Firm provides a range of compliance-related consulting services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.